Adverum Bio Stock (NASDAQ:ADVM)


ForecastOwnershipFinancialsChart

Previous Close

$6.25

52W Range

$6.00 - $29.70

50D Avg

$7.48

200D Avg

$10.16

Market Cap

$128.35M

Avg Vol (3M)

$187.92K

Beta

1.01

Div Yield

-

ADVM Company Profile


Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

121

IPO Date

Jul 31, 2014

Website

ADVM Performance


ADVM Financial Summary


Dec 23Dec 22Dec 21
Revenue--$7.50M
Operating Income$-116.09M$-157.13M$-146.12M
Net Income$-117.17M$-154.54M$-145.54M
EBITDA$-116.09M$-150.61M$-141.48M
Basic EPS$-1.16$-1.56$-1.48
Diluted EPS$-1.16$-1.56$-1.48

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q4 20Mar 01, 21 | 11:24 PM
Q2 20Aug 11, 20 | 5:00 PM
Q1 20May 29, 20 | 5:00 PM

Peer Comparison


TickerCompany
MREOMereo BioPharma Group plc
MGTXMeiraGTx Holdings plc
RCKTRocket Pharmaceuticals, Inc.
STOKStoke Therapeutics, Inc.
AVTEAerovate Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
ONCTOncternal Therapeutics, Inc.
ABSIAbsci Corporation
BCELAtreca, Inc.
GLMDGalmed Pharmaceuticals Ltd.
PASGPassage Bio, Inc.
ANTXAN2 Therapeutics, Inc.
KODKodiak Sciences Inc.
AFMDAffimed N.V.
RZLTRezolute, Inc.
RYTMRhythm Pharmaceuticals, Inc.
SLDBSolid Biosciences Inc.
ADAGAdagene Inc.
KZRKezar Life Sciences, Inc.
FIXXQ32 Bio Inc.
QUREuniQure N.V.